| Serial Number | 97790097 |
| Word Mark | INSTACAR |
| Filing Date | Friday, February 10, 2023 |
| Status | 819 - SU - REGISTRATION REVIEW COMPLETE |
| Status Date | Wednesday, October 22, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 1, 2024 |
| Goods and Services | Cryopreservation of human blood and tissue |
| Goods and Services | Immunotherapy services namely, research and development in the field of cell-based immunotherapy; collection and preservation of biological tissue, blood, and cells, namely, cell culture services for scientific research purposes for others; scientific medical diagnostic services, namely, Blood analysis for scientific or medical research purposes, Blood testing for scientific or medical research purposes, Cell culture and testing services for scientific and research purposes for others; provision of information and data for diagnosis and medical treatment, namely, providing medical and scientific research information in the field of cellular therapies; manipulation of cells for therapeutic purposes, namely, conducting scientific research and development of gene-based medicines and cellular therapies used for medical treatment purposes; Scientific research in the nature of conducting clinical trials for others in relation to immunotherapy pharmaceutical preparations and drugs for the treatment of cancer and autoimmune diseases; Scientific research in the nature of conducting clinical trials for others in relation to cellular therapy pharmaceutical preparations and drugs for the treatment of genetic disorders and degenerative diseases |
| Goods and Services | Medical diagnostic services, namely, Testing for medical diagnostic or treatment purposes using blood and cell samples; Blood testing being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services relating to the removal, treatment and processing of human blood |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 2, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | Tuesday, April 22, 2025 |
| First Use In Commerce Date | Tuesday, April 22, 2025 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 2, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, April 22, 2025 |
| First Use In Commerce Date | Tuesday, April 22, 2025 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 2, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | Tuesday, April 22, 2025 |
| First Use In Commerce Date | Tuesday, April 22, 2025 |
| Party Name | Innovative Cellular Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Rockville, MD 20850 |
| Party Name | Innovative Cellular Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Rockville, MD 20850 |
| Event Date | Event Description |
| Tuesday, February 14, 2023 | NEW APPLICATION ENTERED |
| Wednesday, March 1, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 8, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, November 8, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 8, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 8, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 28, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, December 28, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 29, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 2, 2024 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Friday, February 2, 2024 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
| Friday, February 2, 2024 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Friday, February 2, 2024 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Friday, February 2, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 22, 2024 | ASSIGNED TO LIE |
| Monday, July 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 29, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 11, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 1, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 1, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 26, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 13, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, October 16, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, May 13, 2025 | USE AMENDMENT FILED |
| Monday, October 20, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, October 22, 2025 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, October 22, 2025 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |